• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双管齐下的经皮硬化治疗术治疗巨囊型淋巴管畸形。

Dual-agent percutaneous sclerotherapy technique for macrocystic lymphatic malformations.

机构信息

Neurointerventional Radiology, University of California San Francisco, San Francisco, California, USA

Neurointerventional Radiology, University of California San Francisco, San Francisco, California, USA.

出版信息

J Neurointerv Surg. 2023 Sep;15(9):931. doi: 10.1136/jnis-2022-019255. Epub 2022 Aug 17.

DOI:10.1136/jnis-2022-019255
PMID:35977819
Abstract

Percutaneous sclerotherapy is an effective technique for treating lymphatic malformations of the head and neck, with clinical success rates exceeding 84%.1 Sodium tetradecyl, which damages lipid membranes and stimulates free radical-induced local damage, and doxycycline, which inhibits angiogenesis, have emerged as the safest and most effective of several available sclerosants.2-4 Although severe periprocedural morbidity is rare, temporary local complications are reported in 14% and skin necrosis or scarring in up to 0.8-5.8% of sclerotherapy procedures.5 As these lesions are frequently located in the face and/or neck, even minor complications can be disfiguring and must be avoided. This technical video describes a 'dual-agent' approach for percutaneous sclerotherapy of macrocystic lymphatic malformations using sodium tetradecyl as a 'primer' followed by doxycycline as a definitive sclerosant (video 1). This technique emphasizes meticulous backtable preparation and effective use of ultrasound and fluoroscopy to minimize complications. neurintsurg;15/9/931/V1F1V1Video 1 .

摘要

经皮硬化治疗是治疗头颈部淋巴管畸形的有效技术,其临床成功率超过 84%。1 十四烷基硫酸钠(破坏脂质膜并刺激自由基诱导的局部损伤)和多西环素(抑制血管生成)已成为几种可用硬化剂中最安全有效的药物。2-4 虽然围手术期严重发病率罕见,但在 14%的硬化治疗中报告了暂时的局部并发症,皮肤坏死或瘢痕形成高达 0.8-5.8%。5 由于这些病变通常位于面部和/或颈部,即使是轻微的并发症也可能造成毁容,必须避免。本技术视频描述了一种使用十四烷基硫酸钠作为“底漆”,随后使用多西环素作为确定性硬化剂的“双药”经皮硬化治疗大囊型淋巴管畸形的方法(视频 1)。该技术强调了仔细的后台准备和有效利用超声和透视来最小化并发症。neurintsurg;15/9/931/V1F1V1Video 1。

相似文献

1
Dual-agent percutaneous sclerotherapy technique for macrocystic lymphatic malformations.双管齐下的经皮硬化治疗术治疗巨囊型淋巴管畸形。
J Neurointerv Surg. 2023 Sep;15(9):931. doi: 10.1136/jnis-2022-019255. Epub 2022 Aug 17.
2
Efficacy of doxycycline and sodium tetradecyl sulfate sclerotherapy in pediatric head and neck lymphatic malformations.强力霉素和十四烷基硫酸钠硬化疗法治疗小儿头颈部淋巴管畸形的疗效
Int J Pediatr Otorhinolaryngol. 2015 Jun;79(6):883-887. doi: 10.1016/j.ijporl.2015.03.024. Epub 2015 Apr 6.
3
Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience.经皮硬化治疗新生儿和婴儿头颈部淋巴管畸形:单中心经验。
J Pediatr Surg. 2011 Nov;46(11):2083-95. doi: 10.1016/j.jpedsurg.2011.07.004.
4
Sclerotherapy for lymphatic malformations of the head and neck in the pediatric population.小儿头颈部淋巴管畸形的硬化治疗
J Neurointerv Surg. 2017 Oct;9(10):1023-1026. doi: 10.1136/neurintsurg-2016-012660. Epub 2016 Oct 5.
5
Percutaneous sclerotherapy for head and neck lymphatic malformations in neonates and infants ≤12 months of age.新生儿和≤12 月龄婴儿头颈部淋巴管畸形的经皮硬化治疗。
J Neurointerv Surg. 2023 Dec;15(12):1242-1246. doi: 10.1136/jnis-2022-019516. Epub 2022 Nov 22.
6
Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations.经皮引流和消融作为巨囊型和微囊型眼眶淋巴管畸形的一线治疗方法。
Ophthalmic Plast Reconstr Surg. 2012 Mar-Apr;28(2):119-25. doi: 10.1097/IOP.0b013e318242ab0f.
7
Percutaneous sclerotherapy with ethanolamine oleate for lymphatic malformations of the head and neck.经皮注射油酸乙醇胺硬化治疗头颈部淋巴管畸形
J Neurointerv Surg. 2014 Nov;6(9):691-4. doi: 10.1136/neurintsurg-2013-010925. Epub 2013 Oct 23.
8
Real-time MRI-guided percutaneous sclerotherapy of low-flow head and neck lymphatic malformations in the pediatric population - a stepwise approach.实时MRI引导下小儿头颈部低流量淋巴管畸形的经皮硬化治疗——一种逐步治疗方法
Pediatr Radiol. 2017 May;47(6):755-760. doi: 10.1007/s00247-017-3789-x. Epub 2017 Feb 17.
9
Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy.多西环素硬化治疗儿童淋巴管畸形:疗效、并发症及临床疗效。
Pediatr Radiol. 2012 Sep;42(9):1080-8. doi: 10.1007/s00247-012-2406-2. Epub 2012 May 31.
10
Percutaneous sclerotherapy of microcystic lymphatic malformations: the use of an innovative gravity-dependent technique.经皮硬化治疗微囊性淋巴管畸形:一种创新的重力依赖技术的应用。
J Neurointerv Surg. 2023 Mar;15(3):272-275. doi: 10.1136/neurintsurg-2021-018526. Epub 2022 Mar 28.

引用本文的文献

1
Efficacy of ultrasound-guided microwave ablation for vascular malformations in children.超声引导下微波消融治疗儿童血管畸形的疗效
J Vasc Surg Venous Lymphat Disord. 2025 Mar 25;13(4):102240. doi: 10.1016/j.jvsv.2025.102240.
2
A new therapy for microcystic lymphatic malformations: the combination of intralesional laser thermolysis and percutaneous sclerotherapy.微囊性淋巴管畸形的一种新疗法:病灶内激光热解与经皮硬化疗法联合应用
Front Cell Dev Biol. 2024 Dec 24;12:1490351. doi: 10.3389/fcell.2024.1490351. eCollection 2024.
3
Congenital Vascular Malformations in Children: From Historical Perspective to a Multidisciplinary Approach in the Modern Era-A Comprehensive Review.
儿童先天性血管畸形:从历史视角到现代的多学科方法——全面综述
Children (Basel). 2024 May 8;11(5):567. doi: 10.3390/children11050567.